Phoenix PharmaLabs Inc - Company Review
Phoenix PharmaLabs Inc - Company ReviewSummary
Phoenix PharmaLabs Inc (PPL) is a pre-clinical stage drug development company that develops and commercializes new non-addictive treatments. The company develops therapies for pain and for the treatment of opiate addiction. It designs a opioid drugs with unique opiate receptor characteristics. PPL develops novel family of new molecular entity (NME) opioids that have high binding affinity for all three opiate receptors such as mu opioids, kappa opioids and delta. The company’s PPL-103 derives potent analgesia primarily from mu and kappa. Its technology is based on the discovery of a family of ligands. PPL is headquartered in Woods Cross, Utah, the US.
This comprehensive company report of Phoenix PharmaLabs Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.